VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Stock Comparison
Becton, Dickinson and Company vs ChemoMetec A/S
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Becton, Dickinson and Company
BDX · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Becton, Dickinson and Company's moat claims, evidence, and risks.
View BDX analysisChemoMetec A/S
CHEMM · Nasdaq Copenhagen A/S
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into ChemoMetec A/S's moat claims, evidence, and risks.
View CHEMM analysisComparison highlights
- Moat score gap: ChemoMetec A/S leads (67 / 100 vs 66 / 100 for Becton, Dickinson and Company).
- Segment focus: Becton, Dickinson and Company has 5 segments (29.5% in Medical Essentials); ChemoMetec A/S has 2 segments (94.8% in Life science research, cell and gene therapy, and bioprocessing).
- Primary market structure: Competitive vs Oligopoly. Pricing power: Weak vs Moderate.
- Moat breadth: Becton, Dickinson and Company has 7 moat types across 3 domains; ChemoMetec A/S has 4 across 2.
Primary market context
Becton, Dickinson and Company
Medical Essentials
Single-use medical consumables and specimen collection systems
Global
Healthcare providers and clinical labs
Manufacturer
29.5%
ChemoMetec A/S
Life science research, cell and gene therapy, and bioprocessing
Global cell counting and analysis instruments for LCB workflows
Global, skewed to USA/Canada and Europe
Pharmaceutical, biotech, cell and gene therapy, bioprocessing, and research labs
OEM instrument, consumables, software, and service provider
94.8%
Side-by-side metrics
Moat coverage
Shared moat types
Becton, Dickinson and Company strengths
ChemoMetec A/S strengths
Segment mix
Becton, Dickinson and Company segments
Full profile >Medical Essentials
Competitive
Connected Care
Oligopoly
BioPharma Systems
Oligopoly
Interventional
Competitive
Life Sciences
Oligopoly
ChemoMetec A/S segments
Full profile >Life science research, cell and gene therapy, and bioprocessing
Oligopoly
Production control and quality control of animal semen, beer and milk
Quasi-Monopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.